Ilaria Capasso
YOU?
Author Swipe
View article: Gene actionability according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) in No Specific Molecular Profile (NSMP) endometrial cancer
Gene actionability according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT) in No Specific Molecular Profile (NSMP) endometrial cancer Open
View article: Focal lymphovascular space invasion: Friend or foe? A large retrospective analysis on stage I endometrioid endometrial carcinomas
Focal lymphovascular space invasion: Friend or foe? A large retrospective analysis on stage I endometrioid endometrial carcinomas Open
In stage I endometrioid ECs, LVSI-focal was not associated with reduced oncologic outcomes compared to LVSI-negative. In contrast, LVSI-substantial was associated with aggressive clinicopathologic and molecular features and behaved as an i…
View article: Erratum to ‘Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101664]
Erratum to ‘Primary versus interval cytoreductive surgery in patients with rare epithelial or non-epithelial ovarian cancer’ [International Journal of Gynecological Cancer Volume 35 Issue 3 (2025) 101664] Open
View article: Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience Open
View article: Uterine smooth muscle tumours with uncertain malignant potential: reproductive and clinical outcomes in patients undergoing fertility-sparing management
Uterine smooth muscle tumours with uncertain malignant potential: reproductive and clinical outcomes in patients undergoing fertility-sparing management Open
STUDY QUESTION Can patients with uterine smooth muscle tumours of uncertain malignant potential (STUMP) be effectively and safely managed with fertility-sparing treatment? SUMMARY ANSWER This multicentre retrospective study demonstrates th…
View article: Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese)
Robotic-assisted versus conventional laparoscopic surgery in the management of obese patients with early endometrial cancer in the sentinel lymph node era: a randomized controlled study (RObese) Open
View article: Let go of the myth: safety of indocyanine green for sentinel lymph node mapping in endometrial cancer
Let go of the myth: safety of indocyanine green for sentinel lymph node mapping in endometrial cancer Open
View article: EP238/#102 Support for standardization: ultrasound risk stratification models accurately discriminate benign from malignant adnexal lesions in the hands of novice operator
EP238/#102 Support for standardization: ultrasound risk stratification models accurately discriminate benign from malignant adnexal lesions in the hands of novice operator Open
Introduction It is unclear whether ultrasound risk stratification models for adnexal lesions perform well when used by novice providers. We aim to compare the performance of four commonly used models to detect ovarian cancer, when the oper…
View article: W004/#1411 Support for standardization: ultrasound risk stratification models accurately discriminate benign from malignant adnexal lesions in the hands of novice operator
W004/#1411 Support for standardization: ultrasound risk stratification models accurately discriminate benign from malignant adnexal lesions in the hands of novice operator Open
Introduction It is unclear whether ultrasound risk stratification models for adnexal lesions perform well when used by novice providers. We aim to compare the performance of four commonly used models to detect ovarian cancer, when the oper…
View article: #892 Positive peritoneal cytology in endometrial cancer: is it significant in low-risk disease?
#892 Positive peritoneal cytology in endometrial cancer: is it significant in low-risk disease? Open
Introduction/Background Positive peritoneal cytology (PPC) in endometrial cancer (EC) has been reported as a risk factor for worse oncologic outcomes, but its prognostic role is unclear for patients with low-risk EC. We investigated the pr…
View article: #809 Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients– an international pooled analysis of three ESGO accredited centers
#809 Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients– an international pooled analysis of three ESGO accredited centers Open
Introduction/Background Recently, the new 2023 FIGO staging system for endometrial cancer (EC) critically integrating new pathological and molecular features was published. The present study evaluated the clinical impact of the new 2023 FI…
View article: #56 Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer
#56 Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer Open
Introduction/Background Ultrastaging is accurate in detecting nodal metastases but increases costs and may not be necessary in certain low-risk subgroups. We examine the risk of nodal involvement detected by sentinel lymph node (SLN) biops…
View article: #447 Comparison between immunohistochemical-based model and genomic profiling in endometrial cancer molecular stratification: a propensity-matched survival analysis
#447 Comparison between immunohistochemical-based model and genomic profiling in endometrial cancer molecular stratification: a propensity-matched survival analysis Open
Introduction/Background Nowadays, immunohistochemistry analysis together with POLE sequencing (genomic profiling-based model, GP-M) is the gold-standard for endometrial cancer (EC) classification into molecular classes: POLE-mutated, no sp…
View article: #311 Safety of indocyanine green (ICG) for sentinel lymph node mapping in endometrial cancer
#311 Safety of indocyanine green (ICG) for sentinel lymph node mapping in endometrial cancer Open
Introduction/Background Sentinel lymph node (SLN) mapping by intracervical indocyanine green (ICG) injection has become the standard for nodal staging in endometrial cancer (EC). Adverse reactions to ICG are extremely rare, although inform…
View article: #196 Artificial intelligence-based model for transvaginal ultrasound early detection of endometrial atypical hyperplasia and endometrial cancer in women with postmenopausal bleeding
#196 Artificial intelligence-based model for transvaginal ultrasound early detection of endometrial atypical hyperplasia and endometrial cancer in women with postmenopausal bleeding Open
Introduction/Background Postmenopausal vaginal bleeding (PMB) is usually the first manifestation of endometrial cancer (EC) and endometrial atypical hyperplasia (EAH). Transvaginal ultrasound (TVUS) is often the first diagnostic step for P…
View article: #226 Exploring the association between different mismatch repair deficient phenotypes and prognostic factors in endometrial cancer: a descriptive analysis
#226 Exploring the association between different mismatch repair deficient phenotypes and prognostic factors in endometrial cancer: a descriptive analysis Open
Introduction/Background Mismatch repair deficiency (MMRd) accounts for 20–30% of all endometrial cancers (EC). MMRd ECs are characterized by the loss of at least one of the MMR proteins (MLH1/PMS2/MSH2/MSH6) at immunohistochemistry (IHC), …
View article: #534 Prognosis of surgically staged FIGO IA uterine carcinosarcoma without myometrial invasion: a multicenter international retrospective cohort study
#534 Prognosis of surgically staged FIGO IA uterine carcinosarcoma without myometrial invasion: a multicenter international retrospective cohort study Open
Introduction/Background Uterine carcinosarcoma (CS) is a rare cancer with poor prognosis. CS without myometrial invasion (MI), such as limited to the endometrial lining/polyp or with no residual uterine disease at the time of hysterectomy …
View article: Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients – An international pooled analysis of three ESGO accredited centres Open
The new 2023 FIGO stating system led to a substantial stage shift in about one quarter of patients leading to a higher prognostic precision. In early stage disease, the new substages added further prognostic granularity and identified trea…
View article: 14 Prognostic role of the molecular classification in endometrial cancer patients with cervical stromal invasion
14 Prognostic role of the molecular classification in endometrial cancer patients with cervical stromal invasion Open
Cervical stromal invasion (CSI) in endometrial cancer (EC) is rare, but it is a sign of a disease that is either biologically aggressive, or a tumor that grew for a significant time in patients who had delayed medical care. The optimal tre…
View article: Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer
Lynch Syndrome and Gynecologic Tumors: Incidence, Prophylaxis, and Management of Patients with Cancer Open
This review provides a comprehensive update on recent evidence regarding gynecologic tumors associated with Lynch Syndrome (LS). Endometrial cancer (EC) and ovarian cancer (OC) are the first and second most common gynecologic malignancies …
View article: 2022-RA-585-ESGO Come back to the future: the impact of estrogen receptor profile in the era of molecular endometrial cancer classification
2022-RA-585-ESGO Come back to the future: the impact of estrogen receptor profile in the era of molecular endometrial cancer classification Open
View article: EPV106/#249 Endometrial cancer immunohistochemical risk stratification in a large uterine-confined cancer series
EPV106/#249 Endometrial cancer immunohistochemical risk stratification in a large uterine-confined cancer series Open
Objectives The aim of this study is to assess the clinical reproducibility and the oncological validity of the Endometrial cancer (EC) risk stratification based on the molecular information given by the immunohistochemistry (IHC). Methods …
View article: 86 Endometrial Cancer Immunohistochemical Risk Stratification in a large uterine-confined cancer series
86 Endometrial Cancer Immunohistochemical Risk Stratification in a large uterine-confined cancer series Open
Introduction/Background* Nowadays, after the recent insights about the molecular Endometrial cancer (EC) classification, the usual key histological parameters (i.e histotype and grade) have been shown to have poor reproducibility and adequ…
View article: Laparoscopic vs. robotic-assisted laparoscopy in endometrial cancer staging: large retrospective single-institution study
Laparoscopic vs. robotic-assisted laparoscopy in endometrial cancer staging: large retrospective single-institution study Open
In our large retrospective analysis, we confirmed that the RS and LPS have similar efficacy and safety for endometrial cancer staging also for the high-risk endometrial cancer patients.
View article: 25 Endometrial cancer: laparoscopy vs robotic surgery. A large single-institution retrospective analysis
25 Endometrial cancer: laparoscopy vs robotic surgery. A large single-institution retrospective analysis Open
Introduction Minimally invasive surgery (MIS) is the gold standard for endometrial cancer staging. Among MIS approaches, laparoscopy (LPS) and robotic surgery (RS) are the major techniques. The aim of this study is to compare these two app…
View article: 37 Quantitative evaluation of lymph-vascular space invasion (LVSI) in patients affected by endometrial cancer: prognostic and clinical implications
37 Quantitative evaluation of lymph-vascular space invasion (LVSI) in patients affected by endometrial cancer: prognostic and clinical implications Open
Objectives Lymph-vascular space invasion (LVSI) is associated with an increased risk of recurrence. Usually, the interpretation of LVSI is just qualitative, as presence or absence. The aim of this study is to examine the quantitative analy…
View article: Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study
Uraemic symptom burden and clinical condition in women and men of ≥65 years of age with advanced chronic kidney disease: results from the EQUAL study Open
Background The epidemiology and prognosis of chronic kidney disease (CKD) differ by sex. We aimed to compare symptom prevalence and the clinical state in women and men of ≥65 years of age with advanced CKD receiving routine nephrology care…